![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 40, 30024-30035, October 6, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in Platelet Signaling,
IIb
3 Activation, and Thromboxane A2 Release*
From the Research Center, Montreal Heart Institute and University of Montreal, Montreal, Quebec H1T 1C8, Canada
The protein kinase C (PKC) family is an essential signaling mediator in platelet activation and aggregation. However, the relative importance of the major platelet PKC isoforms and their downstream effectors in platelet signaling and function remain unclear. Using isolated human platelets, we report that PKC
, but not PKC
or PKC
, is required for collagen-induced phospholipase C-dependent signaling, activation of
IIb
3, and platelet aggregation. Analysis of PKC
phosphorylation and translocation to the membrane following activation by both collagen and thrombin indicates that it is positively regulated by
IIb
3 outside-in signaling. Moreover, PKC
triggers activation of the mitogen-activated protein kinase-kinase (MEK)/extracellular-signal regulated kinase (ERK) and the p38 MAPK signaling. This leads to the subsequent release of thromboxane A2, which is essential for collagen-induced but not thrombin-induced platelet activation and aggregation. This study adds new insight to the role of PKCs in platelet function, where PKC
signaling, via the MEK/ERK and p38 MAPK pathways, is required for the secretion of thromboxane A2.
Received for publication, May 10, 2006 , and in revised form, July 28, 2006.
* This work was supported by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Laboratory of Experimental Pathology, Research Center, Montreal Heart Institute, 5000 Belanger St., Montreal, PQ H1T 1C8, Canada. Tel.: 514-376-3330 (ext. 3035); Fax: 514-376-1355; E-mail: yahye.merhi{at}icm-mhi.org.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio, and E. A. Podrez Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI Blood, February 15, 2008; 111(4): 1962 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoffmeister, P. Riha, O. Neumuller, O. Danielewski, J. Schultess, and A. P. Smolenski Cyclic Nucleotide-dependent Protein Kinases Inhibit Binding of 14-3-3 to the GTPase-activating Protein Rap1GAP2 in Platelets J. Biol. Chem., January 25, 2008; 283(4): 2297 - 2306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Marwali, C.-P. Hu, B. Mohandas, A. Dandapat, P. Deonikar, J. Chen, I. Cawich, T. Sawamura, M. Kavdia, and J. L. Mehta Modulation of ADP-Induced Platelet Activation by Aspirin and Pravastatin: Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1, Nitric Oxide, Oxidative Stress, and Inside-Out Integrin Signaling J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1324 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strehl, I. C. A. Munnix, M. J. E. Kuijpers, P. E. J. van der Meijden, J. M. E. M. Cosemans, M. A. H. Feijge, B. Nieswandt, and J. W. M. Heemskerk Dual Role of Platelet Protein Kinase C in Thrombus Formation: STIMULATION OF PRO-AGGREGATORY AND SUPPRESSION OF PROCOAGULANT ACTIVITY IN PLATELETS J. Biol. Chem., March 9, 2007; 282(10): 7046 - 7055. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |